Dr. Nicholas J. Silvestri, MD

Dr. Silvestri practices at University Neurology, Inc. in Williamsville, New York.

Dr. Silvestri's NPI, 1073783858, was assigned on March 7, 2008. Dr. Silvestri graduated from State University of New York at Buffalo School of Medicine in 2004. Dr. Silvestri holds New York license 252113.

Dr. Silvestri's primary practice is University Neurology, Inc., at 5851 Main St, Williamsville, NY 14221 in Erie County. The practice phone is (716) 878-2497.

Dr. Silvestri's primary practice is University Neurology, Inc. in Williamsville, New York. The medical group on file is Kaleida Health. Dmand AI also links Dr. Silvestri to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silvestri practices. Vendor and product names are available with a free account.

Neurology is Dr. Silvestri's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Silvestri is board certified in neuromuscular medicine by the American Board of Physical Medicine and Rehabilitation. Dr. Silvestri is licensed in New York.

CMS data shows 121 Medicare services from Dr. Silvestri across 3 procedure codes in 2024, for 93 Medicare patients. Medicare paid $11,230 for them.

CMS counts 93 Medicare patients who saw Dr. Silvestri in 2024. The largest group is under 65, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silvestri's median patient age at 68, with 46% women.

In 2024, Dr. Silvestri wrote 1,679 Medicare Part D claims for 142 patients. 85% of them were for generic drugs. CMS names the drug for 1,494 of them, across 43 drugs with 11 or more claims each, at $2,934,164 in total drug cost. In 2023, CMS named 1,448 claims across 37 drugs.

Dmand AI links 47 papers to Dr. Silvestri, published from 2013 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Myasthenia Gravis, Myelin Sheath and Receptors, Cholinergic. Dr. Silvestri has published most often in Muscle Nerve. Dr. Silvestri's most frequent co-authors are Gil I. Wolfe, MD, Michael K. Hehir, MD and Kelly G. Gwathmey, MD.

Dmand AI links Dr. Silvestri to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Myasthenia Gravis, Neuromuscular Junction Diseases and Miller Fisher Syndrome. Open Payments lists research payments to Dr. Silvestri that name 1 trial.

CMS Open Payments shows 685 general payments to Dr. Silvestri from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Alexion Pharmaceuticals, Inc. paid the most, $215,666. It also lists 7 research payments totaling $11,125 from 2023 to 2025, naming 1 clinical trial.

Dr. Silvestri graduated from State University of New York at Buffalo School of Medicine in 2004.